• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前放化疗与单纯根治性手术的比较。一项关于口腔和口咽晚期鳞状细胞癌的前瞻性、多中心、随机DOSAK研究(3年随访)。

Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).

作者信息

Mohr C, Bohndorf W, Carstens J, Härle F, Hausamen J E, Hirche H, Kimmig H, Kutzner J, Mühling J, Reuther J

机构信息

Klinik für Gesichts- und Kieferchirurgie, Universitätsklinik Essen, Germany.

出版信息

Int J Oral Maxillofac Surg. 1994 Jun;23(3):140-8. doi: 10.1016/s0901-5027(05)80288-7.

DOI:10.1016/s0901-5027(05)80288-7
PMID:7930766
Abstract

A multicentric, randomized study of squamous cell carcinoma (SCC) of the oral cavity and the oropharynx has been undertaken by DOSAK. The results after radical surgery alone have been compared with the results of combined preoperative radiochemotherapy followed by radical surgery. Patients with primary (biopsy proven) SCC of the oral cavity or the oropharynx with tumor nodes metastasis (TNM) stages T2-4, N0-3, M0 were included in the study. A total of 141 patients were treated by radical surgery alone, whereas 127 patients were treated by radical surgery preceded by preoperative radiochemotherapy. The preoperative treatment consisted of conventionally fractioned irradiation on the primary and the regional lymph nodes with a total dose of 36 Gy (5 x 2 Gy per week) and low-dose cisplatin chemotherapy with 5 x 12.5 mg cisplatin per m2 of body surface during the first week of treatment. Radical surgery according to the DOSAK definitions (DOSAK, 1982) was performed after a delay of 10-14 days. During the follow-up period, 28.2% of all patients suffered from locoregional recurrence, and 27.2% of the patients died. The percentages were higher after radical surgery alone for locoregional recurrence (31% and 15.6%) and for death (28% and 18.6%). The life-table analysis showed improved survival rates of 4.5% after 1 year and 8.3% after 2 years in the group of patients treated with combined therapy. The demonstrated improvement appeared to be significant with the Gehan-Wilcoxon test as well as with the log rank test below a P value of 5%.

摘要

多中心口腔与口咽鳞状细胞癌(SCC)随机研究已由多中心口腔与口咽鳞状细胞癌研究组(DOSAK)开展。单纯根治性手术后的结果已与术前放化疗联合根治性手术的结果进行了比较。口腔或口咽原发性(活检证实)鳞状细胞癌伴肿瘤淋巴结转移(TNM)分期为T2 - 4、N0 - 3、M0的患者被纳入研究。141例患者仅接受根治性手术治疗,而127例患者接受术前放化疗后再进行根治性手术。术前治疗包括对原发灶和区域淋巴结进行常规分割照射,总剂量为36 Gy(每周5次,每次2 Gy),并在治疗的第一周进行低剂量顺铂化疗,每平方米体表面积使用5×12.5 mg顺铂。根据多中心口腔与口咽鳞状细胞癌研究组(DOSAK)定义(DOSAK,1982年)进行的根治性手术在延迟10 - 14天后进行。在随访期间,所有患者中有28.2%出现局部区域复发,27.2%的患者死亡。单纯根治性手术后局部区域复发(分别为31%和15.6%)和死亡(分别为28%和18.6%)的比例更高。生命表分析显示,联合治疗组患者1年后生存率提高了4.5%,2年后提高了8.3%。经Gehan - Wilcoxon检验以及P值低于5%的对数秩检验,所显示的改善似乎具有显著性。

相似文献

1
Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).术前放化疗与单纯根治性手术的比较。一项关于口腔和口咽晚期鳞状细胞癌的前瞻性、多中心、随机DOSAK研究(3年随访)。
Int J Oral Maxillofac Surg. 1994 Jun;23(3):140-8. doi: 10.1016/s0901-5027(05)80288-7.
2
Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.口腔和口咽癌的综合治疗模式,包括新辅助动脉内顺铂治疗和根治性手术,随后进行每周一次多西他赛的同步放化疗——一项前瞻性研究的三年结果
J Craniomaxillofac Surg. 2002 Apr;30(2):112-20. doi: 10.1054/jcms.2002.0283.
3
[Preoperative radio-chemotherapy and radical surgery for advanced carcinomas of the oral cavity. 4-year results of a prospective therapy study with DOSAK].
Dtsch Z Mund Kiefer Gesichtschir. 1990 Jul-Aug;14(4):242-9.
4
Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients.II-IV期口腔和口咽癌的术前放化疗及根治性切除术:222例患者的治疗结果
Int J Oral Maxillofac Surg. 2005 Mar;34(2):143-8. doi: 10.1016/j.ijom.2004.04.003.
5
[Preoperative radiochemotherapy for advanced oral cavity tumours : the Kiel DOSAK experience regarding curability and quality of life].[晚期口腔肿瘤的术前放化疗:基尔多学科口腔鳞状细胞癌研究组关于治愈率和生活质量的经验]
Mund Kiefer Gesichtschir. 2006 Jul;10(4):249-57. doi: 10.1007/s10006-006-0008-6.
6
Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.术前超分割加速放疗联合根治性手术治疗晚期头颈癌:一项前瞻性II期研究。
Radiother Oncol. 2006 Feb;78(2):146-51. doi: 10.1016/j.radonc.2005.11.002. Epub 2005 Nov 22.
7
Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx--an analysis of 174 patients in south western Finland.口腔、口咽和下咽鳞状细胞癌的治疗——芬兰西南部174例患者的分析
Acta Oncol. 2003;42(7):756-62. doi: 10.1080/02841860310010907.
8
[Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts].[顺铂与紫杉醇/卡铂用于晚期可切除口腔癌的术前放化疗。两种多模式治疗方案分析]
Mund Kiefer Gesichtschir. 2006 Jan;10(1):30-6. doi: 10.1007/s10006-005-0659-8.
9
Postoperative chemotherapy with cisplatin and 5-fluorouracil in cancer of the oral cavity and the oropharynx--long-term results.口腔和口咽癌术后顺铂和5-氟尿嘧啶化疗——长期结果
J Chemother. 2003 Oct;15(5):495-502. doi: 10.1179/joc.2003.15.5.495.
10
Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients.术前放化疗治疗晚期口腔癌:276例患者的治疗结果
J Craniomaxillofac Surg. 2009 Sep;37(6):344-7. doi: 10.1016/j.jcms.2008.11.012. Epub 2009 Jun 13.

引用本文的文献

1
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.治疗口腔和口咽癌的干预措施:化疗。
Cochrane Database Syst Rev. 2021 Dec 20;12(12):CD006386. doi: 10.1002/14651858.CD006386.pub4.
2
Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment.口腔和口咽癌的治疗干预措施:手术治疗
Cochrane Database Syst Rev. 2018 Dec 24;12(12):CD006205. doi: 10.1002/14651858.CD006205.pub4.
3
Clinicopathological evaluation of pre-operative chemoradiotherapy with S-1 as a treatment for locally advanced oral squamous cell carcinoma.
以S-1为基础的术前放化疗治疗局部晚期口腔鳞状细胞癌的临床病理评估
Oncol Lett. 2016 May;11(5):3369-3376. doi: 10.3892/ol.2016.4411. Epub 2016 Apr 5.
4
Increased expression of interleukin-6 predicts poor response to chemoradiotherapy and unfavorable prognosis in oral squamous cell carcinoma.白细胞介素-6表达增加预示口腔鳞状细胞癌对放化疗反应不佳及预后不良。
Oncol Rep. 2015 May;33(5):2161-8. doi: 10.3892/or.2015.3838. Epub 2015 Mar 6.
5
Evaluation of neo-adjuvant, concurrent and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma: a meta-analysis.新辅助、同步和辅助化疗治疗头颈部鳞状细胞癌的疗效评估:一项荟萃分析。
J Dent (Tehran). 2014 May;11(3):290-301. Epub 2014 May 31.
6
Intraoperative frozen section histological analysis of resection samples is useful for the control of primary lesions in patients with oral squamous cell carcinoma.术中对切除样本进行冰冻切片组织学分析,有助于口腔鳞状细胞癌患者原发灶的控制。
Mol Clin Oncol. 2015 Jan;3(1):55-62. doi: 10.3892/mco.2014.409. Epub 2014 Sep 4.
7
Head and neck reconstruction using microsurgery: a 9-year retrospective study.头颈部重建术的应用:9 年回顾性研究。
Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2737-43. doi: 10.1007/s00405-013-2390-7. Epub 2013 Feb 16.
8
Multicenter phase II trial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma.多中心 II 期临床试验:术前 S-1 化疗放疗治疗局部晚期口腔鳞状细胞癌。
Cancer Chemother Pharmacol. 2013 Apr;71(4):1059-64. doi: 10.1007/s00280-013-2101-5. Epub 2013 Feb 3.
9
Systemic therapy strategies for head-neck carcinomas: Current status.头颈部癌的全身治疗策略:现状
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc03. doi: 10.3205/cto000085. Epub 2012 Dec 20.
10
Neoadjuvant chemoradiation in squamous cell carcinoma of the maxillary sinus: a 26-year experience.上颌窦鳞状细胞癌的新辅助放化疗:26年经验
Chemother Res Pract. 2012;2012:413589. doi: 10.1155/2012/413589. Epub 2012 Sep 29.